PROSTATE CANCER METASTATIC DISEASE
Clinical trials for PROSTATE CANCER METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CANCER METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for PROSTATE CANCER METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diet and exercise may cut heart risks for men on prostate cancer therapy
Disease control Recruiting nowThis study looks at whether a calorie-controlled, anti-inflammatory diet combined with walking can reduce heart disease risk factors in men with advanced prostate cancer who are on hormone therapy (ADT). The researchers want to see if African American men respond differently than…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for Hard-to-Treat prostate cancer: HLD-0915 trial opens
Disease control Recruiting nowThis early-stage trial tests a new drug called HLD-0915 in men with metastatic castration-resistant prostate cancer (mCRPC) whose cancer has worsened despite prior treatments. The study has two parts: first, finding a safe dose, then testing how well that dose works. About 33 par…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Halda Therapeutics OpCo, Inc. • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Smart scans may guide better prostate cancer treatment
Disease control Recruiting nowThis study tests whether adding targeted local therapy to standard hormone treatment can delay disease progression in men with metastatic hormone-sensitive prostate cancer. Participants first receive hormone therapy for 8 months, then those with remaining active tumors seen on a …
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated May 04, 2026 16:24 UTC
-
Glow-in-the-Dark dye could help surgeons find hidden prostate cancer
Diagnosis Recruiting nowThis study tests a special dye called OTL78 that makes prostate cancer cells glow during surgery. The goal is to help surgeons see and remove cancer that might otherwise be missed. About 22 men with aggressive prostate cancer will take part. The dye is given before surgery and a …
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Clinton Bahler • Aim: Diagnosis
Last updated May 17, 2026 01:49 UTC
-
New scan could sharpen prostate cancer detection
Diagnosis Recruiting nowThis study tests a new imaging agent called FAPI to see if it can find prostate cancer tumors more accurately than current scans. Thirty adults with prostate cancer will get two PET/MRI scans. The goal is to improve how doctors detect and monitor the disease.
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Wisconsin, Madison • Aim: Diagnosis
Last updated May 13, 2026 16:04 UTC
-
Hot flash hope: new drug tested for men on prostate cancer therapy
Symptom relief Recruiting nowThis study tests if fezolinetant, a drug used for hot flashes in women, can reduce hot flashes in men with prostate cancer who are on hormone therapy. About 60 men will take either the drug or a placebo daily for 4 weeks. Researchers will track hot flash frequency, severity, and …
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: PHASE2 • Sponsor: Shehzad Basaria, M.D. • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC
-
Lab-Grown Mini-Tumors could personalize prostate cancer care
Knowledge-focused Recruiting nowThis study aims to improve how doctors choose treatments for aggressive prostate cancer. Researchers will grow 3D mini-tumors from patient samples and test different therapies on them to see which works best. The goal is to find the most effective lab technique for predicting ind…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Sponsor: Maastricht Radiation Oncology • Aim: Knowledge-focused
Last updated May 17, 2026 01:50 UTC
-
New scan could save time and money for prostate cancer patients
Knowledge-focused Recruiting nowThis study looks at whether a type of scan called SPECT/CT can help doctors see if treatment is working in men with advanced prostate cancer. The treatment uses a radioactive drug (Lu-177 PSMA) that targets cancer cells. Researchers want to see if SPECT/CT, which is cheaper and m…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
New scan may catch returning prostate cancer earlier after focal therapy
Knowledge-focused Recruiting nowThis study looks at whether adding a special scan called PSMA PET to the usual MRI can help find prostate cancer that comes back after focal therapy (a treatment that targets only the tumor). About 62 men who have had focal therapy will get both scans. The goal is to see if the P…
Matched conditions: PROSTATE CANCER METASTATIC DISEASE
Phase: NA • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 06, 2026 16:02 UTC